Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Eurofins launches cutting-edge biomarker discovery and bioanalytical services laboratory in Aurora, Colorado

11 May 2007 - Eurofins announced that their newly-established laboratory in the Fitzsimons Biotech Park in Aurora, Colorado is now fully operational and, operating under the Eurofins | Medinet brand, extends the Eurofins network of central laboratories in Europe, Asia and the US to provide services for our customers in the pharmaceutical clinical trial and drug development sector.
 
The Eurofins | Medinet laboratory in Aurora provides mass spectrometry-based technologies for the development, validation and measurement of biomarkers and biomarker strategies. This includes targeted and non-targeted biochemical profiling (metabolomics) and protein profiling (proteomics). In addition, the laboratory offers the development and validation of assays for the quantification of endogenous compounds, drugs and their metabolites based on highly sensitive and specific mass spectrometry assays as well as bioanalytical services for all stages of drug development. The Aurora laboratory is strategically located next to the new University of Colorado Health Sciences Center campus and has strong collaborative links with university researchers. Eurofins | Medinet in Aurora is led by General Manager Professor Uwe Christians.